Bristol Myers Squibb is a global biopharmaceutical leader dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. The company focuses on specialty therapeutic areas where there is a high unmet medical need, leveraging advanced science to transform the treatment of cancer, cardiovascular conditions, and autoimmune disorders.
BMS delivers 'Innovation that Transforms Lives' by providing profound clinical benefit in high-acuity specialty areas and offering therapeutic options for diseases with previously limited treatment paths.
AI Visibility Score
Bristol Myers Squibb has an AI visibility score of 44/100, rated as low. This score reflects how often and how prominently Bristol Myers Squibb appears in responses from AI assistants like ChatGPT, Claude, and Gemini.
AI Perception Summary
Bristol Myers Squibb is currently missing a critical opportunity to establish itself as an AI-driven authority, remaining largely absent from core clinical and treatment-related conversations where it should be a primary reference. While the brand maintains a notable presence in oncology-specific discussions, its failure to appear in essential clinical efficacy and medication management queries allows competitors to capture the trust of decision-makers by default.
Strengths
- Secured a position in AI Overviews for high-level clinical innovation and trust queries.
- Effective brand resonance within oncology-focused leadership discussions, maintaining a strong position in relevant search results.
Visibility Gaps
- Total absence in high-intent queries regarding standard of care options for metastatic conditions.
- Complete lack of visibility in anticoagulation and cardiovascular management, allowing smaller specialized players like Medisafe and MyTherapy to dominate.
- Failure to provide authoritative content for Clinical Research Leads and Specialized Care Advocates, key personas for long-term clinical adoption.
Competitors in AI Recommendations
- Medisafe: 1 mentions
- MyTherapy: 1 mentions
- American Heart Association (HF Helper): 1 mentions
- EveryDose: 1 mentions
- AdhereTech: 1 mentions
- Pillsy: 1 mentions
- Tenovi Pillbox: 1 mentions
- Proteus: 1 mentions
- HeartGuardian: 1 mentions
- Roche (Genentech, Tecentriq, Herceptin, Avastin): 1 mentions
- Merck & Co. (Keytruda): 1 mentions
- Johnson & Johnson (Stelara, Tremfya, Darzalex): 1 mentions
- AstraZeneca (Tagrisso, Imfinzi, Enhertu): 1 mentions
- AbbVie (Humira, Skyrizi, Rinvoq, Imbruvica, Venclexta): 1 mentions
- Novartis (Kymriah): 1 mentions
Categories: Healthcare / Pharmaceuticals